Amelia Deitchman, PharmD, PhD

Title(s)Assistant Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Address2540 23rd Street, #2804
San Francisco CA 94110
Phone415-476-1148
PronounsShe/Her/Hers
ORCID ORCID Icon0000-0002-4722-463X Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Florida, Gainesville, FLPharmD05/2013
    University of Florida, Gainesville, FLPhD12/2017Pharmaceutical Sciences
    University of California, San Francisco, San Francisco, CA01/2020T32 Clinical Pharmacology Fellowship

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Clinical Pharmacology Approaches towards Accelerating HIV Cure Initiatives
    NIH K23AI162249Aug 27, 2021 - Jul 31, 2026
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. COVID-19 clinical presentation, management, and epidemiology: a concise compendium. Front Public Health. 2025; 13:1498445. Maison DP, Tasissa H, Deitchman A, Peluso MJ, Deng Y, Miller FD, Henrich TJ, Gerschenson M. PMID: 39957982; PMCID: PMC11826932.
      View in: PubMed   Mentions:    Fields:    
    2. Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant. Sci Rep. 2025 Jan 24; 15(1):3028. Thomas S, Roche E, Desai P, Pawlowska N, Bauer D, Gingrich D, Hsu E, Deitchman AN, Aweeka F, Munster PN. PMID: 39848945; PMCID: PMC11758070.
      View in: PubMed   Mentions:    Fields:    
    3. Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV. Cell Rep Med. 2024 Oct 15; 5(10):101745. Henrich TJ, Bosch RJ, Godfrey C, Mar H, Nair A, Keefer M, Fichtenbaum C, Moisi D, Clagett B, Buck AM, Deitchman AN, Aweeka F, Li JZ, Kuritzkes DR, Lederman MM, Hsue PY, Deeks SG, ACTG A5337 Team. PMID: 39321793; PMCID: PMC11513808.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    4. The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms. J Med Virol. 2023 11; 95(11):e29216. Buck AM, Deitchman AN, Takahashi S, Lu S, Goldberg SA, Bodansky A, Kung A, Hoh R, Williams MC, Kerbleski M, Maison DP, Deveau TM, Munter SE, Lombardo J, Wrin T, Petropoulos CJ, Durstenfeld MS, Hsue PY, Kelly JD, Greenhouse B, Martin JN, Deeks SG, Peluso MJ, Henrich TJ. PMID: 37988251; PMCID: PMC10754238.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCellsPHPublic Health
    5. A long-term fulvestrant eluting implant is safe, non-toxic, and reduces the risk of breast cancer in in vivo models. Res Sq. 2023 Oct 23. Thomas S, Roche E, Desai P, Pawlowska N, Bauer D, Gingrich D, Hsu E, Deitchman AN, Aweeka F, Munster PN. PMID: 37961240; PMCID: PMC10635313.
      View in: PubMed   Mentions:
    6. Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs. Eur Respir J. 2023 08; 62(2). Ernest JP, Goh JJN, Strydom N, Wang Q, van Wijk RC, Zhang N, Deitchman A, Nuermberger E, Savic RM. PMID: 37321622; PMCID: PMC10469274.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    7. Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies. Viruses. 2023 05 09; 15(5). Buck AM, Deveau TM, Henrich TJ, Deitchman AN. PMID: 37243212; PMCID: PMC10222761.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    8. The Breadth of the Neutralizing Antibody Response to Original SARS-CoV-2 Infection is Linked to the Presence of Long COVID Symptoms. medRxiv. 2023 Mar 31. Buck AM, Deitchman AN, Takahashi S, Lu S, Goldberg SA, Hoh R, Williams MC, Kerbleski M, Deveau TM, Munter SE, Lombardo J, Wrin T, Petropoulos CJ, Durstenfeld MS, Hsue PY, Kelly JD, Greenhouse B, Martin JN, Deeks SG, Peluso MJ, Henrich TJ. PMID: 37034660; PMCID: PMC10081395.
      View in: PubMed   Mentions:
    9. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative. Front Immunol. 2023; 14:1129459. Bonilla H, Peluso MJ, Rodgers K, Aberg JA, Patterson TF, Tamburro R, Baizer L, Goldman JD, Rouphael N, Deitchman A, Fine J, Fontelo P, Kim AY, Shaw G, Stratford J, Ceger P, Costantine MM, Fisher L, O'Brien L, Maughan C, Quigley JG, Gabbay V, Mohandas S, Williams D, McComsey GA. PMID: 36969241; PMCID: PMC10034329.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    10. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023 02 01; 133(3). Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, Chan F, Lu S, Goldberg SA, Hoh R, Tai V, Torres L, Iyer NS, Deswal M, Ngo LH, Buitrago M, Rodriguez A, Chen JY, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Deitchman AN, Hellmuth J, Spinelli MA, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, Deeks SG, Hunt PW, Henrich TJ. PMID: 36454631; PMCID: PMC9888380.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansCells
    11. Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs. bioRxiv. 2023 Jan 20. Ernest JP, Ni Goh JJ, Strydom N, Wang Q, van Wijk RC, Zhang N, Deitchman A, Nuermberger E, Savic RM. PMID: 36711493; PMCID: PMC9882354.
      View in: PubMed   Mentions:
    12. Evaluating the effect of atorvastatin exposure and vitamin D levels on lipid outcomes in people with HIV-1 with suppressed HIV-1 RNA and LDL cholesterol <130 mg/dL. HIV Med. 2023 06; 24(6):749-753. Rahman F, Brates I, Aweeka F, Bosch RJ, Deitchman A, Nixon D, Aberg JA. PMID: 36549898; PMCID: PMC10257730.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    13. Female Genital Fibroblasts Diminish the In Vitro Efficacy of PrEP against HIV. Viruses. 2022 08 04; 14(8). George AF, McGregor M, Gingrich D, Neidleman J, Marquez RS, Young KC, Thanigaivelan KL, Greene WC, Tien PC, Deitchman AN, Spitzer TL, Roan NR. PMID: 36016345; PMCID: PMC9413545.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    14. First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody. Nat Commun. 2022 03 09; 13(1):1219. Beckford-Vera DR, Flavell RR, Seo Y, Martinez-Ortiz E, Aslam M, Thanh C, Fehrman E, Pardons M, Kumar S, Deitchman AN, Ravanfar V, Schulte B, Wu IK, Pan T, Reeves JD, Nixon CC, Iyer NS, Torres L, Munter SE, Hyunh T, Petropoulos CJ, Hoh R, Franc BL, Gama L, Koup RA, Mascola JR, Chomont N, Deeks SG, VanBrocklin HF, Henrich TJ. PMID: 35264559; PMCID: PMC8907355.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsCTClinical Trials
    15. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021 08 10; 36(6):109518. Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. PMID: 34358460; PMCID: PMC8342976.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansCells
    16. Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease. Open Forum Infect Dis. 2021 Aug; 8(8):ofab393. Peluso MJ, Munter SE, Lynch KL, Yun C, Torres L, Iyer NS, Donatelli J, Ryan L, Deitchman AN, Deeks SG, Rutishauser RL, Henrich TJ. PMID: 34395717; PMCID: PMC8344490.
      View in: PubMed   Mentions: 2  
    17. Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis. J Infect Dis. 2021 06 04; 223(11):1855-1864. Bigelow KM, Deitchman AN, Li SY, Barnes-Boyle K, Tyagi S, Soni H, Dooley KE, Savic RM, Nuermberger EL. PMID: 31993638; PMCID: PMC8176636.
      View in: PubMed   Mentions: 15     Fields:    Translation:Animals
    18. Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus. J Infect Dis. 2021 05 20; 223(9):1621-1630. Schnittman SR, Deitchman AN, Beck-Engeser G, Ahn H, York VA, Hartig H, Hecht FM, Martin JN, Deeks SG, Aweeka FT, Hunt PW. PMID: 32915986; PMCID: PMC8136975.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    19. Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19. medRxiv. 2021 Mar 01. Peluso MJ, Deitchman AN, Torres L, Iyer NS, Nixon CC, Munter SE, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman E, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. PMID: 33688685; PMCID: PMC7941662.
      View in: PubMed   Mentions:
    20. Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV. J Acquir Immune Defic Syndr. 2020 12 15; 85(5):651-658. Gingrich D, Deitchman AN, Kantor A, Huang L, Stein JH, Currier JS, Hsue PY, Ribaudo HJ, Aweeka FT, ACTG 5314 Protocol Team. PMID: 33177476; PMCID: PMC8132144.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    21. Supporting Precision Dosing in Drug Labeling. Clin Pharmacol Ther. 2021 01; 109(1):37-41. Neely M, Onufrak N, Scheetz MH, Avedissian S, Lakota E, Deitchman AN, Gonzalez D. PMID: 33111328.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study. Am J Transplant. 2021 05; 21(5):1765-1779. Henrich TJ, Schreiner C, Cameron C, Hogan LE, Richardson B, Rutishauser RL, Deitchman AN, Chu S, Rogers R, Thanh C, Gibson EA, Zarinsefat A, Bakkour S, Aweeka F, Busch MP, Liegler T, Baker C, Milush J, Deeks SG, Stock PG. PMID: 32780519; PMCID: PMC9177122.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    23. The Risk of Treating Populations Instead of Patients. CPT Pharmacometrics Syst Pharmacol. 2019 05; 8(5):256-258. Deitchman AN. PMID: 30884214; PMCID: PMC6539720.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    24. Nonlinear Protein Binding: Not What You Think. J Pharm Sci. 2018 07; 107(7):1754-1760. Deitchman AN, Singh RSP, Derendorf H. PMID: 29626534; PMCID: PMC6042850.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    25. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses). Circ Genom Precis Med. 2018 04; 11(4):e001854. McDonough CW, Magvanjav O, Sá ACC, El Rouby NM, Dave C, Deitchman AN, Kawaguchi-Suzuki M, Mei W, Shen Y, Singh RSP, Solayman M, Bailey KR, Boerwinkle E, Chapman AB, Gums JG, Webb A, Scherer SE, Sadee W, Turner ST, Cooper-DeHoff RM, Gong Y, Johnson JA. PMID: 29650764; PMCID: PMC5901893.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    26. Enhanced in vitro activity of tigecycline in the presence of chelating agents. Int J Antimicrob Agents. 2018 May; 51(5):799-802. Deitchman AN, Singh RSP, Rand KH, Derendorf H. PMID: 29305959; PMCID: PMC5940551.
      View in: PubMed   Mentions: 2     Fields:    Translation:Cells
    27. A need to revisit clinical breakpoints of tigecycline: effect of atypical non-linear plasma protein binding. Int J Antimicrob Agents. 2017 Apr; 49(4):449-455. Singh RSP, Mukker JK, Drescher SK, Deitchman AN, Derendorf H. PMID: 28237830.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    28. Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization. AAPS J. 2017 03; 19(2):334-342. Deitchman AN, Heinrichs MT, Khaowroongrueng V, Jadhav SB, Derendorf H. PMID: 27943149.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    29. Ceftobiprole medocaril (BAL-5788) for the treatment of complicated skin infections. Expert Rev Anti Infect Ther. 2016; 14(11):997-1006. Deitchman A, de Jong D, Barbour A, Derendorf H. PMID: 27690689.
      View in: PubMed   Mentions:    Fields:    
    30. Role of Divalent Metal Ions in Atypical Nonlinear Plasma Protein Binding Behavior of Tigecycline. J Pharm Sci. 2016 11; 105(11):3409-3414. Singh RSP, Mukker JK, Deitchman AN, Drescher SK, Derendorf H. PMID: 27616672.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    31. Measuring drug distribution in the critically ill patient. Adv Drug Deliv Rev. 2014 Nov 20; 77:22-6. Deitchman AN, Derendorf H. PMID: 25194997.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    32. Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage Adjustments. Ther Adv Infect Dis. 2014 Feb 01; 2(1):17-42. B?dingen FV, Gonzalez D, Tucker AN, Derendorf H. PMID: 24949199; PMCID: PMC4059611.
      View in: PubMed   Mentions: 11  
    Amelia's Networks
    Concepts (131)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (44)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-9-g3adcefa5 on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.